✦ LIBER ✦

Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases

✍ Scribed by Barbara M. Sampson; M. Greaves; R. G. Malia; F. E. Preston

Book ID: 114710039
Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 661 KB
Volume: 54
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1983.tb02091.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acquired type II von Willebrand's diseas

Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment

✍ J. Goudemand; B. Samor; C. Caron; B. Jude; D. Gosset; C. Mazurier 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 814 KB

The use of a chromogenic assay for facto

The use of a chromogenic assay for factor VIII in patients with factor VIII inhibitors or von Willebrand's disease

✍ R.A. Hutton; A. Kamiguti Yamaga; K.B. Matthews; B.J. Woodhams 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Idiopathic immune-mediated acquired von

Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: Demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor

✍ Alhumood, Salah A.; Devine, Dana V.; Lawson, Laurie; Nantel, Stephen H.; Carter, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

A case of idiopathic immune-mediated von Willebrand's disease (AvWD) associated angiodysplasia and recurrent lower gastrointestinal bleeding is reported. Coagulation parameters at presentation were activated partial thromboplastin time of 41 sec, bleeding time >15 min, factor VIII procoagulant activ

Response of Factor VIII/von Willebrand F

Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's Disease

✍ P. M. Mannucci; M. T. Canciani; L. Rota; B. S. Donovan 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 665 KB

Clinical efficacy and safety of the fact

Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE® in patients with von Willebrand’s disease: a prospective multi-centre study

✍ S. DUNKLEY; R. I. BAKER; M. PIDCOCK; J. PRICE; M. SELDON; M. SMITH; A. STREET; D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

On the characterization of acquired inhi

On the characterization of acquired inhibitors to ristocetin induced platelet aggregation found in patients with von Willebrand's disease

✍ Nils Egberg; Margareta Blombäck 📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 413 KB